Recommendationsc Annual screening for cystic fibrosis–related diabetes with oral glucosetolerance test should begin by age10 years in all patients with cystic fibrosisnot previously diagnosed withcystic fibrosis–related diabetes. Bc A1C is not recommended as ascreening test for cystic fibrosis–related diabetes. Bc Patients with cystic fibrosis–relateddiabetes should be treated with insulinto attain individualized glycemicgoals. Ac Beginning 5 years after the diagnosisof cystic fibrosis–related diabetes,annual monitoring for complicationsof diabetes is recommended. E